| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALBO | Common Stock | Options Exercise | $220K | +9.14K | +114.5% | $24.04 | 17.1K | Jun 24, 2021 | Direct | |
| transaction | ALBO | Common Stock | Options Exercise | $21.3K | +863 | +5.04% | $24.67 | 18K | Jun 24, 2021 | Direct | |
| transaction | ALBO | Common Stock | Sale | -$364K | -10K | -55.62% | $36.38 | 7.98K | Jun 24, 2021 | Direct | F1, F2 |
| transaction | ALBO | Common Stock | Options Exercise | $155K | +6.3K | +78.95% | $24.67 | 14.3K | Jun 25, 2021 | Direct | |
| transaction | ALBO | Common Stock | Sale | -$228K | -6.3K | -44.12% | $36.22 | 7.98K | Jun 25, 2021 | Direct | F1, F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALBO | Stock Option (right to buy) | Options Exercise | $0 | -9.14K | -47.59% | $0.00 | 10.1K | Jun 24, 2021 | Common Stock | 9.14K | $24.04 | Direct | F5 |
| transaction | ALBO | Stock Option (right to buy) | Options Exercise | $0 | -863 | -2.74% | $0.00 | 30.6K | Jun 24, 2021 | Common Stock | 863 | $24.67 | Direct | F6 |
| transaction | ALBO | Stock Option (right to buy) | Options Exercise | $0 | -6.3K | -20.56% | $0.00 | 24.3K | Jun 25, 2021 | Common Stock | 6.3K | $24.67 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.01 to $36.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| F4 | Represents 292 shares of common stock and 7,688 restricted stock units. Includes 131 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2021. |
| F5 | This option vested as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023. |
| F6 | This option vested as to 25% of the shares on January 21, 2021, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2021 and ending on January 21, 2024, provided that the vesting of the option may be accelerated, in whole or in part, based on the achievement of certain pre-established company performance criteria, but in no event prior to January 21, 2021. |